BfArM — authorised 19 July 2006
- Marketing authorisation holder: Pfizer Limited
- Status: approved
BfArM authorised Sutent on 19 July 2006
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. BfArM authorised it on 19 July 2006.
Pfizer Limited holds the German marketing authorisation.